Güney Murat Can, Süygün Hakan, Polat Melike, Ayhan Hüseyin, Keleş Telat, Turinay Ertop Zeynep Şeyma, Karasu Betül Banu, Bozkurt Engin
Department of Cardiology, Faculty of Medicine, Medicana International Ankara Hospital, Atılım University, Söğütözü, 2176. Sk. No: 3, Çankaya 06510, Turkey.
Department of Cardiology, Faculty of Medicine, Karamanoglu Mehmetbey University, Karaman Training and Research Hospital, Karaman 70100, Turkey.
Medicina (Kaunas). 2025 Feb 4;61(2):266. doi: 10.3390/medicina61020266.
: Patients with reduced left ventricular ejection fraction (LVEF) are reported to have unfavorable outcomes following transcatheter aortic valve implantation (TAVI). This study aims to evaluate outcomes and identify predictive factors for LVEF recovery following TAVI in patients with reduced LVEF. : This retrospective study analyzed 114 patients with symptomatic severe aortic stenosis (AS) with LVEF < 40% who underwent TAVI between 2011 and 2023 at two centers. Echocardiographic parameters, including LVEF, ventricular dimensions, and relative wall thickness (RWT), were assessed at baseline and during follow-up. The outcomes and predictors of substantial LVEF improvement and mortality were analyzed using univariate and multivariate logistic regression methods. : Anemia (OR = 4.345, 95% CI: 1.208-15.626, = 0.024), RWT (OR = 1.224, 95% CI: 1.064-1.407, = 0.005), and early post-procedural changes in left ventricular end-systolic dimension (LVESD) (OR = 1.297, 95% CI: 1.037-1.622, = 0.023) and left ventricular end-diastolic dimension (LVEDD) (OR = 1.346, 95% CI: 1.034-1.753, = 0.027) at one-month follow-up were identified as significant factors associated with LVEF recovery at one year. Regarding factors related to mortality, higher baseline AVMG levels were associated with a lower probability of death after one year (OR = 0.926, 95% CI: 0.875-0.979, = 0.007). Conversely, a more limited increase in LVEF from baseline to the final follow-up was linked to poor prognosis and higher mortality at one year (95% CI: 1.045-1.594, = 0.018). : This study demonstrated that TAVI in patients with AS and reduced LVEF can be performed with high procedural success, low mortality, and significant improvement in cardiac function during follow-up. Additionally, anemia, baseline RWT, and early post-procedural changes in LVESD and LVEDD were identified as factors associated with LVEF recovery. Baseline AVMG and changes in LVEF at the final follow-up were found to be significant predictors of total mortality.
据报道,左心室射血分数(LVEF)降低的患者在经导管主动脉瓣植入术(TAVI)后预后不佳。本研究旨在评估TAVI治疗LVEF降低患者后的预后,并确定LVEF恢复的预测因素。 :这项回顾性研究分析了2011年至2023年期间在两个中心接受TAVI治疗的114例有症状的重度主动脉瓣狭窄(AS)且LVEF<40%的患者。在基线和随访期间评估超声心动图参数,包括LVEF、心室大小和相对室壁厚度(RWT)。使用单因素和多因素逻辑回归方法分析LVEF显著改善和死亡率的预后及预测因素。 :贫血(OR = 4.345,95%CI:1.208 - 15.626,P = 0.024)、RWT(OR = 1.224,95%CI:1.064 - 1.407,P = 0.005)以及术后1个月左心室收缩末期内径(LVESD)(OR = 1.297,95%CI:1.037 - 1.622,P = 0.023)和左心室舒张末期内径(LVEDD)(OR = 1.346,95%CI:1.034 - 1.753,P = 0.027)的早期变化被确定为与1年时LVEF恢复相关的显著因素。关于与死亡率相关的因素,较高的基线主动脉平均梯度(AVMG)水平与1年后较低的死亡概率相关(OR = 0.926,95%CI:0.875 - 0.979,P = 0.007)。相反,从基线到最终随访LVEF增加更有限与1年时预后不良和较高死亡率相关(95%CI:1.045 - 1.594,P = 0.018)。 :本研究表明,AS且LVEF降低的患者进行TAVI手术成功率高、死亡率低,且随访期间心脏功能有显著改善。此外,贫血、基线RWT以及LVESD和LVEDD的术后早期变化被确定为与LVEF恢复相关的因素。基线AVMG和最终随访时LVEF的变化被发现是总死亡率的显著预测因素。